{"organizations": [], "uuid": "afc9d98719b93e4087359f8711d1d49708e3e1c6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/us-express-scripts-results/express-scripts-reports-62-percent-rise-in-quarterly-profit-idUSKCN1GB2WV", "country": "US", "domain_rank": 408, "title": "UPDATE 1-Express Scripts quarterly profit beats on higher patient claims", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T23:57:00.000+02:00", "replies_count": 0, "uuid": "afc9d98719b93e4087359f8711d1d49708e3e1c6"}, "author": "", "url": "https://www.reuters.com/article/us-express-scripts-results/express-scripts-reports-62-percent-rise-in-quarterly-profit-idUSKCN1GB2WV", "ord_in_thread": 0, "title": "UPDATE 1-Express Scripts quarterly profit beats on higher patient claims", "locations": [], "entities": {"persons": [], "locations": [{"name": "wall street", "sentiment": "none"}], "organizations": [{"name": "anthem inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "express scripts holding co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Reuters) - Pharmacy benefit manager Express Scripts Holding Co ( ESRX.O ) reported fourth-quarter profit on Tuesday above Wall Street estimates, benefiting from a rise in patient claims and strong customer retention.\nShares of the company rose 3.6 percent at $81.44 after the bell.\nThe company also forecast a consolidated customer retention rate for 2018 in the range of 96 percent to 98 percent.\nIn October, Express Scripts bought privately held eviCore healthcare, a move that helped the company widen its reach beyond prescription drugs.\nThe deal came at a time when Express Scriptsâ€™ biggest client and health insurer Anthem Inc ( ANTM.N ) ended a 10-year contract, saying it would manage its patient prescriptions starting 2020.\nThe company posted a net profit of $2.33 billion, or $4.10 per share, in the quarter ended Dec. 31, from $1.43 billion, or $2.34 per share, a year earlier.\nExcluding items, Express Scripts earned $2.16 per share, beating the average analyst estimate of $2.09 per share, according to Thomson Reuters I/B/E/S.\nRevenue rose 2.1 percent to $25.38 billion.\nReporting by Anuron Kumar Mitra; Editing by Arun Koyyur\n ", "external_links": [], "published": "2018-02-27T23:57:00.000+02:00", "crawled": "2018-02-28T00:11:41.011+02:00", "highlightTitle": ""}